Featured Research

from universities, journals, and other organizations

Experts question whether preventive drugs are value for money

Date:
April 19, 2011
Source:
BMJ-British Medical Journal
Summary:
Writing in a new article, experts challenge the view that popular drugs to prevent disease -- like statins and anti-hypertensives to prevent heart disease and stroke, or bisphosphonates to prevent fractures -- represent value for money.

Experts are challenging the view that popular drugs to prevent disease -- like statins and antihypertensives to prevent heart disease and stroke, or bisphosphonates to prevent fractures -- represent value for money.

In a paper published online in the British Medical Journal, Teppo Jδrvinen and colleagues argue that the benefits seen when these drugs are tested in clinical trials may not apply in the real world.

They argue that value for money in real life clinical practice is likely to be much lower than in a clinical trial, where patients are carefully selected and receive special attention from dedicated staff. "This gap between the ideal and clinical circumstances raises the question of how well our most widely used preventive drugs work in real life," they write.

For example, data from randomised trials suggest that bisphosphonates are a cost effective way to prevent hip fractures in older people. But this is a far cry from reality, say the authors.

Using 2003 data on 7411 hip fractures in Finland, they estimate that giving bisphosphonates to all 1.86 million citizens aged 50 years and over would only guarantee prevention of 343 fractures.

"Thus, although there are claims that important preventive drugs such as statins, antihypertensives, and bisphosphonates are cost effective, there are no valid data on the effectiveness, and particularly the cost effectiveness, in usual clinical care," they say.

Despite this dearth of data, they point out that the majority of clinical guidelines and recommendations for preventive drug therapy rest on these claims.

The authors argue that before claims on cost effectiveness can be used to guide treatment policies and practices, it should be adequately proven by testing in a real-world setting.

"We need to put an end to this kind of gaming of the system and start to advocate true comparative effectiveness research," they conclude. "Unless this is done, the important question whether preventive pharmacotherapy is cost effective will remain unanswered."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. T. L. N. Jarvinen, H. Sievanen, P. Kannus, J. Jokihaara, K. M. Khan. The true cost of pharmacological disease prevention. BMJ, 2011; 342 (apr19 1): d2175 DOI: 10.1136/bmj.d2175

Cite This Page:

BMJ-British Medical Journal. "Experts question whether preventive drugs are value for money." ScienceDaily. ScienceDaily, 19 April 2011. <www.sciencedaily.com/releases/2011/04/110419205723.htm>.
BMJ-British Medical Journal. (2011, April 19). Experts question whether preventive drugs are value for money. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2011/04/110419205723.htm
BMJ-British Medical Journal. "Experts question whether preventive drugs are value for money." ScienceDaily. www.sciencedaily.com/releases/2011/04/110419205723.htm (accessed September 22, 2014).

Share This



More Science & Society News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) — Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Hundreds of Thousands Hit NYC Streets to Protest Climate Change

Hundreds of Thousands Hit NYC Streets to Protest Climate Change

AFP (Sep. 22, 2014) — Celebrities, political leaders and the masses rallied in New York and across the globe demanding urgent action on climate change, with organizers saying 600,000 people hit the streets. Duration: 01:19 Video provided by AFP
Powered by NewsLook.com
Company Copies Keys From Photos

Company Copies Keys From Photos

Newsy (Sep. 22, 2014) — A new company allows customers to make copies of keys by simply uploading a couple of photos. But could it also be great for thieves? Video provided by Newsy
Powered by NewsLook.com
Rockefeller Oil Heirs Switching To Clean Energy

Rockefeller Oil Heirs Switching To Clean Energy

Newsy (Sep. 22, 2014) — The Rockefellers — heirs to an oil fortune that made the family name a symbol of American wealth — are switching from fossil fuels to clean energy. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins